Novartis Strategy and Innovation

Jim interviews Novartis CEO Vass Nairosif on portfolio simplification, margin expansion, and bets on RNA and radioligand therapies.

Play episode from 10:25

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!